CRIS Current Research Information System

CARACENI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.836
AS - Asia 11.207
EU - Europa 11.147
SA - Sud America 771
AF - Africa 699
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 37.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.703
SG - Singapore 3.505
CN - Cina 3.150
IT - Italia 3.143
VN - Vietnam 2.114
GB - Regno Unito 2.101
DE - Germania 1.238
SE - Svezia 1.182
HK - Hong Kong 1.005
IN - India 584
BR - Brasile 535
RU - Federazione Russa 521
FR - Francia 462
NL - Olanda 460
UA - Ucraina 417
IE - Irlanda 355
CH - Svizzera 278
KR - Corea 268
BG - Bulgaria 229
TG - Togo 221
ZA - Sudafrica 183
FI - Finlandia 176
CI - Costa d'Avorio 168
EE - Estonia 158
JP - Giappone 141
JO - Giordania 111
ES - Italia 88
AT - Austria 86
AR - Argentina 85
CA - Canada 70
ID - Indonesia 68
IR - Iran 63
SC - Seychelles 57
BE - Belgio 55
PL - Polonia 48
EC - Ecuador 47
MX - Messico 45
CL - Cile 37
GR - Grecia 28
BD - Bangladesh 26
HR - Croazia 25
UZ - Uzbekistan 25
TR - Turchia 24
NG - Nigeria 22
IQ - Iraq 21
CO - Colombia 18
CZ - Repubblica Ceca 18
PK - Pakistan 18
PY - Paraguay 18
AU - Australia 15
LT - Lituania 13
MY - Malesia 12
PE - Perù 12
RO - Romania 12
IL - Israele 11
PT - Portogallo 11
EG - Egitto 10
LB - Libano 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 8
MA - Marocco 8
SA - Arabia Saudita 8
VE - Venezuela 8
PH - Filippine 7
TN - Tunisia 7
UY - Uruguay 7
AL - Albania 6
EU - Europa 6
CD - Congo 5
KZ - Kazakistan 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
ET - Etiopia 3
HN - Honduras 3
KE - Kenya 3
LU - Lussemburgo 3
MK - Macedonia 3
NO - Norvegia 3
SN - Senegal 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
SI - Slovenia 2
SV - El Salvador 2
VA - Santa Sede (Città del Vaticano) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
Totale 37.676
Salva come PNG Salva come JPEG
Città #
Singapore 2.300
Southend 1.824
Ashburn 1.509
Fairfield 1.433
Chandler 1.137
Hong Kong 994
Dong Ket 773
Santa Clara 721
Woodbridge 717
Hefei 656
Wilmington 642
Seattle 619
Houston 600
Cambridge 547
Bologna 528
Princeton 493
Beijing 433
Boardman 380
Ann Arbor 352
Dublin 352
Ho Chi Minh City 273
Seoul 265
Hanoi 249
Bern 247
Milan 244
Jacksonville 226
Sofia 226
Los Angeles 223
Lomé 221
Dallas 206
Nanjing 194
Westminster 187
Padova 182
Abidjan 168
New York 146
Berlin 143
Rome 135
Tokyo 131
Amman 111
Helsinki 110
Jinan 109
Shenyang 108
Buffalo 103
Florence 97
Saint Petersburg 97
Redondo Beach 91
San Diego 91
Turin 89
Munich 81
Redmond 77
Changsha 72
Frankfurt am Main 68
Bengaluru 64
Medford 64
Shanghai 64
Guangzhou 60
Nanchang 58
Nuremberg 56
Mülheim 55
Hebei 54
São Paulo 53
Dearborn 52
Chicago 50
Brussels 48
Bremen 47
Falkenstein 46
London 46
Tianjin 46
Vienna 45
Jiaxing 43
Zhengzhou 43
Redwood City 41
Jakarta 39
Da Nang 36
Paris 36
Lappeenranta 35
Ningbo 35
Des Moines 34
Hangzhou 34
Falls Church 33
Amsterdam 32
Haiphong 32
Naples 32
Norwalk 30
Olalla 30
Warsaw 29
Phoenix 28
Turku 28
Ardabil 27
Brooklyn 27
Grafing 27
Verona 27
Düsseldorf 26
Barcelona 24
Council Bluffs 24
Leiden 24
Reggio Calabria 24
San Francisco 24
Quận Bình Thạnh 23
Toronto 23
Totale 23.838
Salva come PNG Salva come JPEG
Nome #
L’arterializzazione della vena porta per insuffcienza epatica acuta 659
Arterializzazione della vena porta per il trattamento dell’insufficenza epatica acuta secondaria ad estesa resezione epatica nel ratto. 444
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 312
OS-077 Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF 309
L’albumina nelle malattie del fegato. 285
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 260
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 237
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 230
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 221
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 218
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 215
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 212
Acute Liver Failure Caused by Amanita phalloides Poisoning 211
A novel model of CCl4-induced cirrosi with ascites in the mouse. 207
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 204
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 204
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 201
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 200
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 199
A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge 199
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 196
569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE? 196
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 196
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 194
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 194
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 192
Portal vein arterialization in a patient with acute liver failure 190
Monofocal hepatocellular carcinoma: How much does size matter? 189
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 188
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 186
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 184
L’iponatremia nel paziente con cirrosi epatica. 184
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 184
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 183
Cardiac electrophysiological abnormalities in patients with cirrhosis. 180
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 180
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 179
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 179
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 178
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 178
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 178
Soluble Receptor Activator of Nuclear Factor-kB Ligand (sRANKL)/Osteoprotegerin balance in ageing and age-associated diseases. 176
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 176
Clinical indications for the albumin use: Still a controversial issue. 175
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 174
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 174
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 173
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 173
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 172
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 171
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 171
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 171
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 168
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 168
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 168
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 168
Insufficienza epatica acuta ed epatite subacuta. 167
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 166
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 166
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 165
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study 164
null 164
CCL4-induced acute liver failure with portal vein arterialization in the rat 164
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 164
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 164
Hyperoxia fully protects mitochondria of explanted livers 163
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 163
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 163
Metabolic disorders across hepatocellular carcinoma in Italy 163
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 161
Real-word experience of long-term albumin treatment in a large cohort of patients with cirrhosis and ascites (Real-Answer study) 160
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 160
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 160
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 159
Pattern of macrovascular invasion in hepatocellular carcinoma 159
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 159
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. 157
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 157
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 157
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 156
Complicanze della cirrosi epatica: le infezioni batteriche. 155
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 154
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 154
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 154
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 154
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 153
Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis 153
The endocannabinoid system and liver diseases. 152
First report of fulminant hepatic failure treated with portal vein arterialization avoiding liver transplantation 152
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 151
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 151
Terapia cellulare in Epatologia 150
Consensus conference on TIPS management: Techniques, indications, contraindications 150
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 147
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 147
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 147
Portal vein arterialization: a new surgical option against acute liver failure? 147
The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis 145
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 145
Le infezioni batteriche nel paziente cirrotico. 145
Totale 18.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.609 0 0 0 0 0 171 114 224 356 205 166 1.373
2021/20224.776 410 158 317 369 405 248 155 391 186 274 1.163 700
2022/20235.219 505 753 284 601 321 429 177 294 864 167 402 422
2023/20241.931 122 265 119 190 122 386 112 145 72 143 158 97
2024/20257.029 295 993 570 557 1.063 382 406 229 197 545 367 1.425
2025/20268.145 1.499 1.488 1.509 1.208 1.679 762 0 0 0 0 0 0
Totale 38.490